Method for detecting water-soluble vitamins in parenteral nutrition medicine
Detection of vitamins B2, B5, and B6 in parenteral nutrition drugs through high performance liquid chromatography has solved the problem of lack of detection methods in the existing technology, achieved effective quality control of parenteral nutrition drugs, and ensured the effectiveness of the drugs and security.
Patent Information
- Application Number
- CN202411257534.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-09
- Publication Date
- 2024-12-06
AI Technical Summary
The prior art lacks detection methods for vitamins B2, B5, and B6 in the complete nutrition mixture after compatibility, resulting in the inability to effectively control the quality and effectiveness of parenteral nutrition drugs.
High performance liquid chromatography was used to separate and detect water-soluble vitamins in parenteral nutritional drugs. The mobile phase was buffered solution of ammonium dihydrogen phosphate-phosphate and acetonitrile, with pH range of 2.0~4.0, gradient elution method is used, and the detection wavelengths are 210nm, 287nm and 445nm.
It realizes effective detection of vitamins B2, B5, and B6 in the fatty lactoamino acid glucose injection combination mixture, ensuring the quality control of the drug, simple and fast operation, and high sensitivity.
Smart Images

Figure CN119086757A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of substance detection, and in particular to a method for detecting water-soluble vitamins in parenteral nutrition medicines. Background Art
[0002] As a parenteral nutrition drug, fat emulsion (10%) / amino acid (15) / glucose (20%) injection is mainly used for parenteral nutrition when oral or enteral nutrition is impossible, insufficient or contraindicated, and has a high market value. The 23rd batch of generic drug reference preparations released by the State Drug Administration shows that this variety is an internationally recognized drug listed in China. The fat emulsion (10%) / amino acid (15) / glucose (20%) currently sold on the market is a ready-to-use premixed commercial parenteral nutrition three-chamber bag, one chamber for fat emulsion injection, one chamber for amino acid injection containing electrolytes, and one chamber for glucose injection containing calcium. In the clinical use process, the doctor will add nutrients such as vitamins, trace elements and electrolytes to form an "all-in-one" complete nutrition mixture according to the needs of the patient to provide better nutritional support.
[0003] The complete nutrient mixture contains fat emulsion injection, amino acid injection, glucose injection, as well as added vitamin injection, trace element injection, and electrolyte injection, and the ingredients are complex. The stability after compatibility will affect the safety and effectiveness of use. At present, the "Technical Guidelines for Pharmaceutical Research on the Stability of Chemical Drug Injection Compatibility (Draft for Comments)" issued by the State Food and Drug Administration and a large number of literature materials focus on the stability of compatibility in terms of physical stability, chemical stability, and biological stability. Among them, the chemical stability research of the compatibility focuses on the content of the original components of the three cavities before compatibility, related substances, and trace elements and electrolytes added after compatibility. There are many studies and research methods, but there is no method for detecting vitamin B2, B5, and B6 in the complete nutrient mixture after compatibility. Therefore, it is not possible to better characterize the amount of vitamin B2, B5, and B6 in the complete nutrient mixture after compatibility. Summary of the invention
[0004] The purpose of the present invention is to provide a method for detecting water-soluble vitamins in parenteral nutrition drugs, which solves the problem that there is no detection means for detecting vitamins B2, B5, and B6 in the complete nutrition mixture after compatibility, and the effectiveness of parenteral nutrition drugs cannot be controlled.
[0005] The present invention is achieved through the following technical solutions:
[0006] The present invention provides a method for detecting water-soluble vitamins in parenteral nutrition drugs, the method comprising: separating and detecting the water-soluble vitamins in the parenteral nutrition drugs by high performance liquid chromatography;
[0007] Among them, parenteral nutrition drugs are fat emulsion amino acid glucose injection mixed liquid drugs;
[0008] Water-soluble vitamins include vitamin B2, vitamin B5, and vitamin B6;
[0009] The chromatographic column for high performance liquid chromatography is an octadecyl bonded silica gel chromatographic column;
[0010] The mobile phase of the HPLC method is a buffer solution of ammonium dihydrogen phosphate-phosphoric acid and acetonitrile, and the pH of the mobile phase is 2.0-4.0;
[0011] High performance liquid chromatography was performed using gradient elution.
[0012] Furthermore, in the method for detecting water-soluble vitamins in parenteral nutrition drugs, the octadecyl bonded silica gel chromatographic column has a silica gel matrix as a skeleton, and an octadecyl group is bonded to the skeleton.
[0013] Furthermore, in the method for detecting water-soluble vitamins in parenteral nutrition drugs, the chromatographic column is an aqueous column resistant to 100% aqueous phase.
[0014] Furthermore, in the method for detecting water-soluble vitamins in parenteral nutrition drugs, the pore size of the chromatographic column is 2.7 μm to 10 μm, the length is 50 mm to 300 mm, and the diameter is 2 mm to 30 mm.
[0015] Furthermore, in the method for detecting water-soluble vitamins in the parenteral nutrition drug, the concentration of diammonium phosphate in the diammonium phosphate-phosphoric acid buffer solution is 20 mmol / L to 80 mmol / L, and the amount of phosphoric acid is determined according to pH.
[0016] Furthermore, in the method for detecting water-soluble vitamins in parenteral nutrition drugs, the fat emulsion amino acid glucose injection mixed liquid drug is fat emulsion amino acid glucose injection, and the fat emulsion amino acid glucose injection is mixed with one or more of vitamin injection, trace element additives and electrolyte additives;
[0017] Wherein, the fat emulsion amino acid glucose injection includes fat emulsion injection, glucose injection, and amino acid injection;
[0018] Preferably, the vitamin injection includes water-soluble vitamins and / or fat-soluble vitamins;
[0019] The water-soluble vitamins include vitamin B2, vitamin B5 and vitamin B6, and the water-soluble vitamins also include at least one of vitamin B1, vitamin B3, vitamin B8, vitamin B9, vitamin B12 and vitamin C;
[0020] Preferably, the vitamin B5 in the water-soluble vitamin is in the form of pantothenic acid or pantothenate, and the salt base is sodium or calcium;
[0021] Preferably, the trace element additive includes at least one of chromium, copper, manganese, zinc, iodine, selenium, molybdenum, iron, fluoride and cobalt;
[0022] Preferably, the electrolyte additive includes at least one of sodium chloride, potassium chloride, magnesium sulfate and calcium gluconate.
[0023] Furthermore, in the method for detecting water-soluble vitamins in parenteral nutrition drugs, the chromatographic conditions of the high performance liquid chromatography are:
[0024] The column temperature is 15-60°C; the flow rate of the mobile phase is 0.3 mL / min-1.5 mL / min; the injection volume is 1 μL-100 μL; the detection wavelength is 190 nm-500 nm; the mobile phase A is a buffer solution of ammonium dihydrogen phosphate-phosphoric acid, and the mobile phase B is acetonitrile.
[0025] Furthermore, in the method for detecting water-soluble vitamins in parenteral nutrition drugs, the setting conditions of the high performance liquid chromatography are:
[0026] The column temperature was 30°C; the flow rate of the mobile phase was 0.5 mL / min; the injection volume was 20 μL; the detection wavelengths were 210 nm, 287 nm, and 445 nm; the mobile phase A was 50 mmol diammonium phosphate solution, and the pH was adjusted to 3.0 with phosphoric acid, and the mobile phase B was acetonitrile.
[0027] Furthermore, in the method for detecting water-soluble vitamins in parenteral nutrition drugs, the detector of the high performance liquid chromatography is an ultraviolet absorption detector.
[0028] Furthermore, in the method for detecting water-soluble vitamins in parenteral nutrition drugs, the high performance liquid chromatography method adopts gradient elution, and the elution procedure is:
[0029] Time / min Mobile phase B / % Mobile phase A% 0 5 95 8 5 95 15 35 65 28 40 60 35 5 95 45 5 95 .
[0030] Compared with the prior art, the present invention has the following advantages and beneficial effects:
[0031] The detection method of water-soluble vitamins in parenteral nutrition drugs provided by the present invention can effectively detect vitamin B2, vitamin B5 and vitamin B6 in the fat emulsion amino acid glucose injection compatibility mixture, which is beneficial to the quality control of the fat emulsion amino acid glucose injection compatibility mixture and ensures the effectiveness of the fat emulsion amino acid glucose injection compatibility mixture. The detection method disclosed by the present invention has the characteristics of strong specificity, simple and fast operation and high sensitivity in the detection method of water-soluble vitamins in the fat emulsion amino acid glucose injection compatibility mixture, and is worthy of being promoted and applied in actual production to control the quality of the fat emulsion amino acid glucose injection compatibility mixture medicine. BRIEF DESCRIPTION OF THE DRAWINGS
[0032] In order to more clearly illustrate the technical solutions of the exemplary embodiments of the present invention, the following briefly introduces the drawings required for use in the embodiments. It should be understood that the following drawings only illustrate certain embodiments of the present invention and should not be regarded as limiting the scope. For ordinary technicians in this field, other relevant drawings can be obtained based on these drawings without creative work.
[0033] In the figure:
[0034] Figure 1 The HPLC diagram of the diluent in Example 1;
[0035] Figure 2 HPLC chart of the control solution in Example 1;
[0036] Figure 3 HPLC diagram of the test solution in Example 1;
[0037] Figure 4 HPLC diagram of the control solution in Example 2;
[0038] Figure 5 This is the HPLC diagram of the test solution in Example 2. DETAILED DESCRIPTION
[0039] In order to make the purpose, technical scheme and advantages of the present invention clearer, the present invention is further described in detail below in conjunction with examples and drawings. The illustrative embodiments of the present invention and their description are only used to explain the present invention and are not intended to limit the present invention. If specific conditions are not specified in the examples, they are carried out according to conventional conditions or conditions recommended by the manufacturer. If the manufacturer is not specified for the reagents or instruments used, they are all conventional products that can be purchased commercially.
[0040] The technical solution of the present invention is:
[0041] A method for detecting water-soluble vitamins in parenteral nutrition drugs, the method comprising: separating and detecting water-soluble vitamins in parenteral nutrition drugs by high performance liquid chromatography;
[0042] Among them, parenteral nutrition drugs are fat emulsion amino acid glucose injection mixed liquid drugs;
[0043] Water-soluble vitamins include vitamin B2, vitamin B5, and vitamin B6;
[0044] The chromatographic column for high performance liquid chromatography is an octadecyl bonded silica gel chromatographic column;
[0045] The mobile phase of the HPLC method is a buffer solution of ammonium dihydrogen phosphate-phosphoric acid and acetonitrile, and the pH of the mobile phase is 2.0-4.0;
[0046] High performance liquid chromatography was performed using gradient elution.
[0047] Furthermore, the octadecyl bonded silica gel chromatographic column has a silica gel matrix as a skeleton, and an octadecyl group is bonded to the skeleton.
[0048] Furthermore, the chromatographic column is an aqueous column resistant to 100% aqueous phase.
[0049] Furthermore, the pore size of the chromatographic column is 2.7 μm to 10 μm, and can be 2.7 μm, 3 μm, 4 μm, 5 μm, 6 μm, 7 μm, 8 μm, 9 μm, 10 μm, etc., but is not limited to the listed values, and other unlisted values within the range are also applicable.
[0050] The length of the chromatographic column is 50 mm to 300 mm, and can be 50 mm, 60 mm, 80 mm, 100 mm, 120 mm, 150 mm, 180 mm, 200 mm, 220 mm, 250 mm, 270 mm, 290 mm, 300 mm, etc., but is not limited to the listed values, and other values not listed within the range are also applicable.
[0051] The diameter of the chromatographic column is 2 mm to 30 mm, and can be 2 mm, 5 mm, 8 mm, 10 mm, 12 mm, 15 mm, 18 mm, 20 mm, 22 mm, 25 mm, 28 mm, 30 mm, etc., but is not limited to the listed values, and other values not listed within the range are also applicable.
[0052] Further, the concentration of ammonium dihydrogen phosphate in the ammonium dihydrogen phosphate-phosphoric acid buffer solution is 20mmol / L to 80mmol / L, and can be 20mmol / L, 25mmol / L, 30mmol / L, 35mmol / L, 40mmol / L, 45mmol / L, 50mmol / L, 55mmol / L, 60mmol / L, 65mmol / L, 70mmol / L, 75mmol / L, 80mmol / L, etc., but is not limited to the listed values, and other unlisted values within the range are also applicable; the amount of phosphoric acid is determined according to the pH.
[0053] Furthermore, the fat emulsion amino acid glucose injection mixed liquid medicine is fat emulsion amino acid glucose injection, and the fat emulsion amino acid glucose injection is mixed with one or more of vitamin injection, trace element additives and electrolyte additives;
[0054] Wherein, the fat emulsion amino acid glucose injection includes fat emulsion injection, glucose injection, and amino acid injection;
[0055] Preferably, the vitamin injection includes water-soluble vitamins and / or fat-soluble vitamins;
[0056] The water-soluble vitamins include vitamin B2, vitamin B5 and vitamin B6, and the water-soluble vitamins also include at least one of vitamin B1, vitamin B3, vitamin B8, vitamin B9, vitamin B12 and vitamin C;
[0057] Preferably, the vitamin B5 in the water-soluble vitamin is in the form of pantothenic acid or pantothenate, and the salt base is sodium or calcium;
[0058] Preferably, the trace element additives include at least one of chromium, copper, manganese, zinc, iodine, selenium, molybdenum, iron, fluoride and cobalt;
[0059] Preferably, the electrolyte additive includes at least one of sodium chloride, potassium chloride, magnesium sulfate and calcium gluconate.
[0060] Furthermore, the chromatographic conditions of the high performance liquid chromatography are:
[0061] The column temperature is 15°C to 60°C, and can be 15°C, 20°C, 25°C, 30°C, 35°C, 40°C, 45°C, 50°C, 55°C, 60°C, etc., but is not limited to the listed values, and other values not listed within the range are also applicable;.
[0062] The flow rate of the mobile phase is 0.3mL / m~1.5mL / min, 0.3mL / min, 0.5mL / min, 0.7mL / min, 0.9mL / min, 1.0mL / min, 1.3mL / min, 1.5mL / min, etc., but is not limited to the listed values, and other values not listed within the range are also applicable.
[0063] The injection volume is 1 μL to 100 μL, which can be 1 μL, 5 μL, 10 μL, 20 μL, 30 μL, 40 μL, 50 μL, 60 μL, 70 μL, 80 μL, 90 μL, 100 μL, etc., but is not limited to the listed values, and other unlisted values within the range are also applicable.
[0064] The detection wavelength is 190-500nm, which can be 190nm, 200nm, 210nm, 240nm, 280nm, 287nm, 300nm, 340nm, 380nm, 400nm, 440nm, 445nm, 480nm, 500nm, etc., but is not limited to the listed values, and other unlisted values within the range are also applicable.
[0065] Mobile phase A was ammonium dihydrogen phosphate-phosphoric acid buffer solution, and mobile phase B was acetonitrile.
[0066] Furthermore, the setting conditions of the high performance liquid chromatography are:
[0067] The column temperature was 30°C; the flow rate of the mobile phase was 0.5 mL / min; the injection volume was 20 μL; the detection wavelengths were 287 nm, 210 nm, and 445 nm; the mobile phase A was 50 mmol diammonium phosphate solution, and the pH was adjusted to 3.0 with phosphoric acid, and the mobile phase B was acetonitrile.
[0068] Furthermore, the detector of the high performance liquid chromatography is an ultraviolet absorption detector.
[0069] Furthermore, the high performance liquid chromatography method adopts gradient elution, and the elution procedure is:
[0070] Time / min Mobile phase B / % Mobile phase A% 0 5 95 8 5 95 15 35 65 28 40 60 35 5 95 45 5 95 .
[0071] In order to further illustrate the present invention, the following describes a method for detecting water-soluble vitamins in a parenteral nutrition drug provided by the present invention in combination with examples. However, it should be understood that these examples are implemented on the premise of the technical scheme of the present invention, and detailed implementation methods and specific operating procedures are given only to further illustrate the features and advantages of the present invention, rather than to limit the claims of the present invention. The protection scope of the present invention is not limited to the following examples.
[0072] Example 1
[0073] 1. Instruments and conditions
[0074] High performance liquid chromatograph: Shimadzu LC-2030C 3D
[0075] Column: Target-AQ C18(2), 4.6×250mm, 5μm
[0076] Mobile phase A: 50mmol / L ammonium dihydrogen phosphate buffer solution (pH 3.0 adjusted with phosphoric acid), mobile phase B: acetonitrile
[0077] Flow rate: 0.5ml / min
[0078] Column temperature: 30°C
[0079] Detection wavelength: 210nm, 287nm, 445nm
[0080] Injection volume: 20 μL
[0081] The detector is a UV absorption detector
[0082] 2. Experimental Procedure
[0083] 2.1 Reagent preparation
[0084] (1) Diluent: 50 mmol / L diammonium phosphate buffer solution (pH adjusted to 3.0 with phosphoric acid) - acetonitrile = 95:5.
[0085] (2) Control stock solution: Weigh 2.030 mg of vitamin B2 control, 5.025 mg of vitamin B5 control, and 2.496 mg of vitamin B6 control, place them in the same 50 ml volumetric flask, add diluent to dissolve and dilute to the scale, shake well, and obtain.
[0086] (3) Control solution: Accurately measure 2.0 ml of the control stock solution and place it in a 20 ml volumetric flask. Add diluent to dilute to the mark and shake well.
[0087] (4) Test solution (mixed solution of fat emulsion, amino acid and glucose injection): Measure 2 ml of multiple trace element injection (II), 1 ml of multiple V for injection (12), 6 ml of sodium chloride injection, 5.4 ml of potassium chloride injection, 1.08 ml of calcium gluconate injection and 720 μl of magnesium sulfate injection, mix well and use as the mixed sample after compatibility; measure 10 ml of fat emulsion injection, 20 ml of compound amino acid injection, 20 ml of glucose injection and 4 ml of the mixed sample, mix well and obtain.
[0088] 2.2 Use high performance liquid chromatography to separate and detect the diluent, control solution and test solution respectively. The chromatograms of the three are as follows: Figures 1 to 3 shown.
[0089] Depend on Figure 1 and 3 It can be seen that the diluent will not affect the detection of vitamin B2, vitamin B5, and vitamin B6 in the test solution. Figure 2 and Figure 3 It can be seen that there are three peaks with little difference in the two figures. Figure 2 From the corresponding control solution, it can be seen that the substances corresponding to the three peaks are vitamin B2 (445nm), vitamin B5 (210nm) and vitamin B6 (287nm). It can be seen that vitamin B2 (445nm), vitamin B5 (210nm) and vitamin B6 (287nm) are detected in the test solution, which means that vitamin B2 (445nm), vitamin B5 (210nm) and vitamin B6 (287nm) are present in the mixed solution of fat emulsion amino acid glucose injection.
[0090] This indicates that the detection disclosed in the present invention can successfully detect the presence of vitamin B2, vitamin B5 and vitamin B6 in the mixed solution of fat emulsion amino acid glucose injection.
[0091] Example 2
[0092] 1. Instruments and conditions
[0093] High performance liquid chromatograph: Shimadzu LC-2030C 3D
[0094] Column: Target-AQ C18(2), 4.6×250mm, 5μm
[0095] Mobile phase A: 50mmol / L ammonium dihydrogen phosphate buffer solution (pH 3.0 adjusted with phosphoric acid), mobile phase B: acetonitrile
[0096] Flow rate: 0.5ml / min
[0097] Column temperature: 30°C
[0098] Detection wavelength: 210nm, 287nm, 445nm
[0099] Injection volume: 20 μL
[0100] The detector is a UV absorption detector
[0101] 2. Experimental Procedure
[0102] 2.1 Reagent preparation
[0103] (1) Diluent: 50 mmol / L diammonium phosphate buffer solution (pH adjusted to 3.0 with phosphoric acid) - acetonitrile = 95:5.
[0104] (2) Preparation of control stock solution: Weigh 2.018 mg of formic acid control, 12.520 mg of acetic acid control, and 2.508 mg of glycolic acid control, place them in the same 50 ml volumetric flask, add diluent to dissolve and dilute to the scale, shake well, and obtain.
[0105] (3) Control solution: Accurately measure 2.0 ml of the control stock solution and place it in a 20 ml volumetric flask. Add diluent to dilute to the mark and shake well.
[0106] (4) Test solution (spiked solution for vitamin deficiency negative compatibility injection): Measure 2 ml of multiple trace element injection (II), 6 ml of sodium chloride injection, 5.4 ml of potassium chloride injection, 1.08 ml of calcium gluconate injection, and 720 μl of magnesium sulfate injection, mix well, and use as the mixed sample after vitamin deficiency compatibility; measure 10 ml of fat emulsion injection, 20 ml of compound amino acid injection, 20 ml of glucose injection, and 3.75 ml of vitamin deficiency mixed sample, mix well, and obtain.
[0107] 2.2 Use high performance liquid chromatography to separate and detect the control solution and the test solution. The chromatograms of the two are as follows: Figure 4 and 5 shown.
[0108] Depend on Figure 1 , 4 And 5 shows that, Figure 4 and Figure 5 There are three peaks with little difference in Figure 5 From the corresponding control solution, it can be seen that the substances corresponding to the three peaks are vitamin B2 (445nm), vitamin B5 (210nm) and vitamin B6 (287nm). It can be seen that vitamin B2 (445nm), vitamin B5 (210nm) and vitamin B6 (287nm) are detected in the test solution, which means that vitamin B2 (445nm), vitamin B5 (210nm) and vitamin B6 (287nm) are present in the mixed solution of fat emulsion amino acid glucose injection.
[0109] In order to verify the reliability, accuracy and stability of the detection method of water-soluble vitamins in parenteral nutrition drugs disclosed in the present invention, the analytical method was verified.
[0110] 1. Exclusivity
[0111] (1) Diluent: acetonitrile (A)-50 mmol / L diammonium phosphate solution (phosphoric acid adjusted to pH 3.0) = 5:95.
[0112] (2) VB2 control stock solution: weigh about 2.018 mg of VB2 → 50 ml (diluent) and shake well.
[0113] (3) VB2 positioning solution: Measure 2 ml → 20 ml (diluent) of VB2 control stock solution and shake well.
[0114] (4) VB5 control stock solution: weigh about 2.051 mg of VB5 → 20 ml (diluent) and shake well.
[0115] (5) VB5 positioning solution: Measure 5 ml → 20 ml (diluent) of VB5 control stock solution and shake well.
[0116] (6) VB6 control stock solution: weigh about 2.053 mg of VB6 → 20 ml (diluent) and shake well.
[0117] (7) VB6 localization solution: Take 1 ml → 20 ml (diluent) of VB6 control stock solution and shake well.
[0118] (8) VB2, B5, B6 mixed control stock solution: Accurately weigh 2.030 mg, 5.025 mg, and 2.496 mg of VB2, B5, and B6, respectively, and place them in the same 50 ml volumetric flask. Dilute to the mark with diluent and shake well.
[0119] (9) Control solution: Accurately pipette 2 ml of the mixed control stock solution of VB2, B5, and B6 into a 20 ml volumetric flask, dilute to the mark with diluent, and shake well.
[0120] Mixed sample: Measure 2 ml of multiple trace elements injection (II), 1 ml of multiple V for injection (12), 6 ml of sodium chloride injection, 5.4 ml of potassium chloride injection, 1.08 ml of calcium gluconate injection, and 720 μl of magnesium sulfate injection, mix well, and the mixture is ready.
[0121] Mixed injection after compatibility: measure 10 ml of fat emulsion injection, 20 ml of compound amino acid injection, 20 ml of glucose injection, and 4 ml of the mixed sample, mix well.
[0122] Vitamin-deficient mixed sample: measure 2 ml of multiple trace elements injection (II), 6 ml of sodium chloride injection, 5.4 ml of potassium chloride injection, 1.08 ml of calcium gluconate injection, and 720 μl of magnesium sulfate injection, mix well, and the mixture is ready.
[0123] Vitamin-deficient negative compatibility injection: Accurately measure 10 ml of fat emulsion injection, 20 ml of compound amino acid injection, 20 ml of glucose injection, and 3.75 ml of V-deficient mixed sample, mix well, and you have it.
[0124] Test sample solution: Mix for injection after preparation.
[0125] Negative sample solution: negative compatible injection solution lacking V.
[0126] Determination: Take solvent, negative blank solution, blank solvent, positioning solution, reference solution and test solution for analysis.
[0127] The statistical results of specificity are shown in Table 1.
[0128] Table 1 Specificity determination results
[0129]
[0130]
[0131] The response peak area of the test sample at the retention time of 21.106 (445nm) is 168.247, and the response peak area of the negative sample at the retention time of 20.981min (445nm) is 3.160, which is 1.9% of the response at the corresponding retention time of the test sample. Therefore, it is assessed that the negative sample does not interfere with the sample detection, so the specificity of the method is good.
[0132] 2. Linearity and range
[0133] Diluent: acetonitrile (A)-50mmol / L diammonium phosphate solution (phosphoric acid adjusted to pH 3.0) = 5:95.
[0134] Mixed control stock solution: Accurately weigh 2.030 mg, 5.025 mg, and 2.496 mg of VB2, B5, and B6 respectively, place them in the same 50 ml volumetric flask, dilute to the scale with diluent, shake well, and obtain.
[0135] Each linear solution: Prepare by mixing the control stock solution according to Table 2.
[0136] Table 2 Preparation of linear solutions
[0137]
[0138] Take the solvent and linear solution, inject and analyze. Use the concentration as the horizontal axis and the peak area as the vertical axis to perform linear fitting.
[0139] Each linear solution was sampled and tested by reverse phase high performance liquid chromatography, and the testing conditions were the same as those in Example 1.
[0140] The statistical results show that: (1) When vitamin B2 is in the range of 1.531μg / ml to 9.183μg / ml, with concentration as X and response signal as Y, the linear regression fitting equation is Y=57.267X+7.2943, and the linear correlation coefficient is 0.995, indicating a good linear relationship.
[0141] (2) When the vitamin B5 concentration was in the range of 5.025 μg / ml to 30.150 μg / ml, with the concentration as X and the response signal as Y, the linear regression fitting equation was Y=4.7424X-1.8544, and the linear correlation coefficient was 0.995, indicating a good linear relationship.
[0142] (3) When the vitamin B6 concentration was in the range of 2.486 μg / ml to 14.916 μg / ml, with the concentration as X and the response signal as Y, the linear regression fitting equation was Y=124.66X-76.493, and the linear correlation coefficient was 0.994, indicating a good linear relationship.
[0143] From the above results, it can be seen that under the detection conditions of the present invention, the peak areas and concentrations of vitamin B2, vitamin B5 and vitamin B6 all have a good linear relationship.
[0144] 3. Precision
[0145] (1) Diluent: acetonitrile-50 mmol / L diammonium phosphate buffer solution (phosphoric acid adjusted to pH 3.0) = 5:95.
[0146] (2) Control stock solution: Accurately weigh 2.018 mg, 12.520 mg, and 2.508 mg of VB2, B5, and B6, respectively, and place them in a 50 ml volumetric flask. Dilute to the mark with diluent and shake well.
[0147] (3) Reference solution: Accurately measure 2 ml of the reference stock solution and place it in a 20 ml volumetric flask. Dilute to the mark with diluent and mix well.
[0148] (4) Test solution (mixed solution of fat emulsion, amino acid and glucose injection): Measure 2 ml of multiple trace element injection (II), 1 ml of multiple V for injection (12), 6 ml of sodium chloride injection, 5.4 ml of potassium chloride injection, 1.08 ml of calcium gluconate injection and 720 μl of magnesium sulfate injection, mix well and use as the mixed sample after compatibility; measure 10 ml of fat emulsion injection, 20 ml of compound amino acid injection, 20 ml of glucose injection and 4 ml of the mixed sample, mix well and obtain.
[0149] The control solution and the test solution were sampled and subjected to reverse phase high performance liquid chromatography detection, and the detection conditions were the same as those in Example 1.
[0150] The precision statistical results are shown in Table 3.
[0151] Table 3 Precision statistical results
[0152]
[0153] The precision results of 6 injections of vitamin B2, vitamin B5, and vitamin B6 in the reference solution and the test solution in Table 3 meet the requirements of precision-repeatability in "Chinese Pharmacopoeia 2020 Edition Volume IV" and "General Chapter 9101 Guiding Principles for Validation of Analytical Methods", indicating that the detection method of the present invention has good precision and good repeatability of the measurement results.
[0154] 4. Accuracy
[0155] (1) Diluent: acetonitrile-50 mmol / L diammonium phosphate buffer solution (phosphoric acid adjusted to pH 3.0) = 5:95.
[0156] (2) Control stock solution: Accurately weigh 2.018 mg, 12.520 mg, and 2.508 mg of VB2, B5, and B6, respectively, and place them in a 50 ml volumetric flask. Dilute to the mark with diluent and shake well.
[0157] (3) Reference solution: Accurately measure 2 ml of the reference stock solution and place it in a 20 ml volumetric flask. Dilute to the mark with diluent and mix well.
[0158] (4) Vitamin-deficient mixed sample: Measure 2 ml of multiple trace element injection (II), 6 ml of sodium chloride injection, 5.4 ml of potassium chloride injection, 1.08 ml of calcium gluconate injection, and 720 μl of magnesium sulfate injection, mix well, and the mixture is ready.
[0159] (5) Vitamin-deficient negative compatibility injection: Accurately measure 15 ml of fat emulsion injection, 30 ml of compound amino acid injection, 30 ml of glucose injection, and 5.63 ml of vitamin-deficient mixed sample, mix well, and the solution is obtained.
[0160] (6) Accuracy solution: Measure 1 ml of the control stock solution and place it in a 10 ml volumetric flask. Add the vitamin-deficient negative injection solution to the mark and shake well. Prepare 6 copies in parallel.
[0161] The control solution and the accuracy solution were sampled and subjected to reverse phase high performance liquid chromatography detection, and the detection conditions were the same as those in Example 1.
[0162] The statistical results are shown in Table 4.
[0163] Table 4 Accuracy test results
[0164]
[0165] It can be seen from Table 4 that when the method of the present invention is used for detection, the recoveries of VB2, VB5 and VB6 are all in the range of 93.9% to 100.4%, and the RSD% of the recoveries of each impurity is less than 2%, indicating that the detection method of the present invention has good accuracy and reliable measurement results.
[0166] It can be seen from the above examples that the detection method provided by the present invention can accurately detect VB2, VB5, and VB6 in the fat emulsion amino acid glucose injection mixed solution. The detection method provided by the present invention has good reliability, accuracy, and stability, is conducive to the quality control of parenteral nutrition drugs, and is therefore worthy of promotion and use.
[0167] The specific implementation methods described above further illustrate the objectives, technical solutions and beneficial effects of the present invention in detail. It should be understood that the above description is only a specific implementation method of the present invention and is not intended to limit the scope of protection of the present invention. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principles of the present invention should be included in the scope of protection of the present invention.
Claims
1. A method for detecting water-soluble vitamins in parenteral nutrition drugs, characterized in that: The detection method comprises: using high performance liquid chromatography to separate and detect water-soluble vitamins in parenteral nutrition drugs; Among them, parenteral nutrition drugs are fat emulsion amino acid glucose injection mixed liquid drugs; Water-soluble vitamins include vitamin B2, vitamin B5, and vitamin B6; The chromatographic column for high performance liquid chromatography is an octadecyl bonded silica gel chromatographic column; The mobile phase of the HPLC method is a buffer solution of ammonium dihydrogen phosphate-phosphoric acid and acetonitrile, and the pH of the mobile phase is 2.0-4.0; High performance liquid chromatography was performed using gradient elution.
2. The method for detecting water-soluble vitamins in parenteral nutrition medicines according to claim 1, characterized in that: The octadecyl bonded silica gel chromatographic column uses a silica gel matrix as a skeleton, and octadecyl groups are bonded to the skeleton.
3. The method for detecting water-soluble vitamins in parenteral nutrition medicines according to claim 1, characterized in that: The chromatographic column is an aqueous column resistant to 100% aqueous phase.
4. The method for detecting water-soluble vitamins in parenteral nutrition medicines according to claim 1, characterized in that: The chromatographic column has a pore size of 2.7 μm to 10 μm, a length of 50 mm to 300 mm, and a diameter of 2 mm to 30 mm.
5. The method for detecting water-soluble vitamins in parenteral nutrition medicines according to claim 1, characterized in that: The concentration of diammonium phosphate in the diammonium phosphate-phosphoric acid buffer solution is 20 mmol / L to 80 mmol / L, and the amount of phosphoric acid is determined according to pH.
6. The method for detecting water-soluble vitamins in parenteral nutrition medicines according to claim 1, characterized in that: The fat emulsion amino acid glucose injection mixed liquid medicine is fat emulsion amino acid glucose injection, and the fat emulsion amino acid glucose injection is mixed with one or more of vitamin injection, trace element additives and electrolyte additives; Wherein, the fat emulsion amino acid glucose injection includes fat emulsion injection, glucose injection, and amino acid injection; Preferably, the vitamin injection includes water-soluble vitamins and / or fat-soluble vitamins; The water-soluble vitamins include vitamin B2, vitamin B5 and vitamin B6, and the water-soluble vitamins also include at least one of vitamin B1, vitamin B3, vitamin B8, vitamin B9, vitamin B12 and vitamin C; Preferably, the vitamin B5 in the water-soluble vitamin is in the form of pantothenic acid or pantothenate, and the salt base is sodium or calcium; Preferably, the trace element additive includes at least one of chromium, copper, manganese, zinc, iodine, selenium, molybdenum, iron, fluoride and cobalt; Preferably, the electrolyte additive includes at least one of sodium chloride, potassium chloride, magnesium sulfate and calcium gluconate.
7. The method for detecting water-soluble vitamins in parenteral nutrition medicines according to claim 1, characterized in that: The chromatographic conditions of the high performance liquid chromatography are: The column temperature is 15°C to 60°C; the flow rate of the mobile phase is 0.3mL / min to 1.5mL / min; the injection volume is 1μL to 100μL; the detection wavelength is 190nm to 500nm; the mobile phase A is a buffer solution of ammonium dihydrogen phosphate-phosphoric acid, and the mobile phase B is acetonitrile.
8. The method for detecting water-soluble vitamins in parenteral nutrition medicines according to claim 7, characterized in that: The setting conditions of the high performance liquid chromatography are: The column temperature was 30°C; the flow rate of the mobile phase was 0.5 mL / min; the injection volume was 20 μL; the detection wavelengths were 210 nm, 287 nm, and 445 nm; the mobile phase A was 50 mmol diammonium phosphate solution, and the pH was adjusted to 3.0 with phosphoric acid, and the mobile phase B was acetonitrile.
9. The method for detecting water-soluble vitamins in parenteral nutrition medicines according to claim 1, characterized in that: The detector of the high performance liquid chromatography is an ultraviolet absorption detector.
10. The method for detecting water-soluble vitamins in parenteral nutrition medicines according to claim 1, characterized in that: The high performance liquid chromatography method adopts gradient elution, and the elution procedure is: 。
